The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cross Alexander D since 2006.
The trader's CIK number is 1182619.
At the time of the last reporting, Cross Alexander D was the Director of Atossa Genetics Inc. (stock ticker symbol ATOS).
Also see all insider trading activities at Atossa Genetics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | LGND | 0 | $0 | 0 | $0 | 1,841 | $6,872 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | ATOS | 500 | $2,745 | 0 | $0 | 0 | $0 |
1. Ligand Pharmaceuticals Inc (LGND)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-03-01 | LGND | Option Ex | 1,841 | 3.73 | 6,872 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-05-15 | ATOS | Buy | 500 | 5.49 | 2,745 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cross Alexander D (Director of Atossa Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.